JENNIFER WALSH

FOLEY & LARDNER LLP · Washington, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

last 3 years

Filings

6 agencies contacted

Activity

filings by quarter

Works on

Health Issues 27 Medicare/Medicaid 9 Medical/Disease Research/Clinical Labs 9 Environment/Superfund 9 Veterans 6 Pharmacy 6 Taxation/Internal Revenue Code 6 Agriculture 6 Utilities 3 Labor Issues/Antitrust/Workplace 3 Consumer Issues/Safety/Products 3 Budget/Appropriations 3 Insurance 3 Telecommunications 2 Science/Technology 2

Background

Government experience

AA; Deputy COS

COS: Rep. Dennis Cardoza; Field Representative: Rep. Vic Fazio; Staff Asst, Program Dir, EA: House Democratic Caucus

Disclosed on LD-2 filings

AA; Deputy COS

COS: Rep. Dennis Cardoza; FieldRepresentative: Rep. Vic Fazio; Staff Asst, Program Dir, EA:House Democratic Caucus

Disclosed on LD-2 filings

AA; Deputy COS

COS: Rep. Dennis Cardoza; Field Representative: Rep. Vic Facio; Staff Asst, Program Dir, EA: House Democratic Caucus

Disclosed on LD-2 filings

Administrative Assistant

Deputy COS, COS: Rep.DennisCardoza; Field Representative: Rep. Vic Fazio; StaffAssistant, Program Director, Executive Assistant: HouseDemocratic Caucus

Disclosed on LD-2 filings

Career

FOLEY & LARDNER LLP

Washington, DC

2024 - present

Specific issues

Issues related to domestic manufacturing; issues related to 340B; issues related to implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Bill; Issues related to supply chain resilience.

Health Issues · 2024 Q3

Remote Cardiac Monitoring

Medical/Disease Research/Clinical Labs · 2024 Q3

California water conveyance; drought legislation; environmental compliance legislation; water supply and availability

Environment/Superfund · 2024 Q3

Personalized Medicine Congressional Caucus

Health Issues · 2024 Q3

Issues related to cosmetics regulations

Consumer Issues/Safety/Products · 2024 Q3

MMM: HR 972 and S312, Medicare beneficiary access to procedures performed in ambulatory surgical centers; ENV: EPA regulation of medical device sterilization; MMM: Medicare beneficiary access to treatments for depression; HCR: Issues related to epilepsy, issues related to telehealth.

Health Issues · 2024 Q3